Related Experiment Video
Updated: Aug 8, 2026

Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c
Published on: June 29, 2011
Betulinic acid induces apoptosis through a direct effect on mitochondria in neuroectodermal tumors
1University Children's Hospital, Ulm, Germany.
Background And Procedure:
We identified BetA as a new cytotoxic agent active against neuroectodermal tumor cells including neuroblastoma, medulloblastoma, glioblastoma and Ewing sarcoma cells, representing the most common solid tumors of childhood.
Results:
BetA induced apoptosis by a direct effect on mitochondria independent of accumulation of wild-type p53 protein and independent of death-inducing ligand/receptor systems such as CD95. Mitochondrial perturbations on treatment with BetA resulted in the release of soluble apoptogenic factors such as cytochrome c or AIF from mitochondria into the cytosol, where they induced activation of caspases. Overexpression of the anti-apoptotic proteins Bcl-2 or Bcl-X(L) that blocked loss of the mitochondrial membrane potential and cytochrome c release from mitochondria also conferred resistance to BetA. Most importantly, BetA exhibited potent antitumor activity on neuroblastoma cells resistant to CD95- or doxorubicin-triggered apoptosis and on primary tumor cells from patients with neuroectodermal tumors.
Conclusions:
Thus, BetA may be a promising new agent in the treatment of neuroectodermal tumors including neuroblastoma in vivo.
Insights
BetA is a novel cytotoxic agent effective against childhood neuroectodermal tumors like neuroblastoma. It triggers apoptosis via mitochondrial pathways, showing promise for treating these aggressive cancers.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Neuroectodermal tumors are the most common childhood solid tumors.
- Effective treatments for these aggressive cancers remain a challenge.
Purpose of the Study:
- To identify and characterize novel cytotoxic agents for neuroectodermal tumors.
- To investigate the mechanism of action of the identified agent, BetA.
Main Methods:
- In vitro screening of cytotoxic agents against neuroectodermal tumor cell lines.
- Apoptosis assays to determine the mechanism of cell death induced by BetA.
- Mitochondrial function and caspase activation studies.
Main Results:
- BetA demonstrated potent cytotoxicity against neuroblastoma, medulloblastoma, glioblastoma, and Ewing sarcoma cells.
- BetA induced apoptosis through direct mitochondrial damage, releasing cytochrome c and AIF, independent of p53 or CD95.
- Overexpression of Bcl-2 or Bcl-X(L) conferred resistance, indicating mitochondrial pathway involvement.
- BetA showed significant antitumor activity against drug-resistant neuroblastoma and primary patient-derived neuroectodermal tumors.
Conclusions:
- BetA represents a promising new therapeutic agent for neuroectodermal tumors.
- Its efficacy against resistant cell types and primary tumors warrants further investigation in vivo.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
12:28Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
Published on: January 11, 2019
Related Concept Videos
Apoptosis
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy